Linke between The Activity of Daily Living and the Sense of Control among Patients with Chronic Liver Disease
DOI:
https://doi.org/10.61841/hg80v662Keywords:
Activity of Daily Living, Sense of Control, Chronic Liver DiseaseAbstract
Background: Chronic liver disease (CLD) is a growing global health concern, contributing to increased mortality and morbidity rates worldwide. This complex condition predominantly affects individuals in their midlife and youth. In recent decades, the number of people affected by CLD has increased to around 550 million due to viral infections alone. The figure rises even higher when including other causes such as fatty liver disease, alcohol consumption, immune disorders, metabolic issues, and cholestasis.
Methodology: A descriptive correlational design was utilized in this study to assess the activities of daily living (ADL) of CLD patients and their sense of control. The study period extended from February to May 2019. Data were gathered using the Arabic version of a structured questionnaire, administered through interviews with patients at the Gastroenterology and Hematology Center in Al-Sadder Medical City. Data collection took place between March 17, 2019, and April 5, 2019.
Results: The findings indicate that the overall assessment of CLD patients' ADL was categorized as *independent*, and their overall sense of control was classified as *moderate*. A significant direct correlation was identified between the ADL of patients and their sense of control. This means that as patients' ADL improved, their sense of control also increased, and vice versa.
Conclusions: The study concludes that CLD patients generally demonstrate a good level of ADL, but their sense of control is less than ideal. Furthermore, there is a direct and positive impact of patients' ADL on their sense of control.
Recommendations: The study recommends further research to identify and develop effective strategies to enhance the ADL and sense of control in CLD patients. Additionally, educational booklets containing information and instructions on ADL and sense of control for CLD patients should be developed and distributed.
Downloads
References
- Al-aboodi, F. H. and Al-dujaily, A. H. (2017) ‘Psychological Aspects Among Patients with Chronic Liver Disease in Al-Najaf Gastroenterology and Hepatology Center’, 8(9).
- Burza, M. A. (2015) Susceptibility to chronic liver disease: Role of environmental and genetic factors.
- Davis, G. L. et al. (2010) ‘Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression’, Gastroenterology. Elsevier Inc., 138(2), pp. 513-521.e6. doi: 10.1053/j.gastro.2009.09.067.
- Enescu, A. et al. (2014) ‘Psychosocial issues in patients with chronic hepatitis B and C’, Current Health Sciences Journal, 40(2), pp. 93–6. doi: 10.12865/CHSJ.40.02.02.
- Eraydin, A. et al. (2014) ‘The validity and reliability of “The liver disease symptom index 2.0” for Turkish society’, Turkish Journal of Gastroenterology, 25(5), pp. 531–538. doi: 10.5152/tjg.2014.7509.
- Gutteling, J. J. et al. (2010) ‘Psychological determinants of health-related quality of life in patients with chronic liver disease’, Psychosomatics, 51(2), pp. 157–65. doi: 10.1176/appi.psy.51.2.157.
- Hung, C. C. et al. (2012) ‘Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions’, Journal of the Chinese Medical Association. Elsevier Taiwan LLC and the Chinese Medical Association, 75(6), pp. 275–280. doi: 10.1016/j.jcma.2012.03.002.
- Hytiroglou, P. et al. (2012) ‘Beyond “cirrhosis”’, American Journal of Clinical Pathology, 137(1), pp. 5–9. doi: 10.1309/AJCP2T2OHTAPBTMP.
- Júnior, O. D. C. (2016) ‘Sociodemographic and clinical characteristics of candidates for liver transplantation’, 29(2), pp. 128–135.
- Liu, Y., Wang, L. and Zhu, Z. (2016) ‘Association of different types of liver disease with demographic and clinical factors’, Biomedicine, 4(2), pp. 151–171. doi: 10.7603/s40.
- Modabbernia, A. et al. (2013) ‘A review of psychosocial issues in patients with chronic hepatitis B’, Archives of Iranian Medicine, 16(2), pp. 114–122.
- Popović, D. D. et al. (2015) ‘Procena depresije i anksioznosti kod bolesnika sa hroničnim bolestima jetre’, Vojnosanitetski Pregled, 72(5), pp. 414–420. doi: 10.2298/VSP130904007P.
- Rehaim, J. A. and Mohamed, I. R. (2017) ‘Knowledge of Patient with Liver Cirrhosis Regarding Ascites Self-Management: Instructions Nursing Guideline’, 6(4), pp. 88–95. doi: 10.9790/1959-0604048895.
- Schulz, K. H. et al. (2008) ‘The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ)’, Quality of Life Research, 17(4), pp. 575–584. doi: 10.1007/s11136-008-9332-7.
- de Souza, N. P. et al. (2015) ‘Assessment of health-related quality of life and related factors in patients with chronic liver disease’, Brazilian Journal of Infectious Diseases. Elsevier Editora Ltda, 19(6), pp. 590–595. doi: 10.1016/j.bjid.2015.08.003.
- Šumskiene, J., Kupčinskas, L. and Šumskas, L. (2015) ‘Health-related quality of life measurement in chronic liver disease patients’, Medicina (Lithuania), 51(4), pp. 201–208. doi: 10.1016/j.medici.2015.06.006.
- Tang, L. S. Y. et al. (2016) ‘Safe and Effective Sofosbuvir-Based Therapy in Patients with Mental Health Disease on Hepatitis C Virus Treatment’, World Journal of Hepatology, 8(31), pp. 1318–1326. doi: 10.4254/wjh.v8.i31.1318.
- Vilstrup, H. et al. (2014) ‘Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver’, Hepatology, 60(2), pp. 715–735. doi: 10.1002/hep.27210.
- Yu, M.-L. et al. (2008) ‘Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial’, Hepatology, 47(6), pp. 1884–1893. doi: 10.1002/hep.22319.
- Zhou, W. C. and Zha Qiao, L. (2010) ‘Pathogenesis of liver cirrhosis’, World Journal of Gastroenterology, 20(23), pp. 7312–7324.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
